Searched for
PARAS PHARMA
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...- Actis exits Sterling Hospital, sells stake to chairman Girish PatelPrivate equity fund Actis said it will sell its 82 per cent holding in Sterling Hospital, which will be bought by the latter's Chairman Gir...
- Paras ex-promoters return to offer more personal care productsDevendra Patel has launched Layer’r brand of perfumes and deodorants, following the footprints of his brother, Darshan, who launched Vini C...
- Former Paras co-promoter launches personal care brand Layer'rFormer Paras Pharma co-promoter Devendra Patel is back in the Rs 30,000 cr personal care market with his new brand Layer’r.
- Vini to invest Rs 40 crore in food supplementsFormer Former Paras Pharma co-founder Darshan Patel will launch nutraceuticals in the Indian market by 2012-end.
- Emami to move to need-based promotion to drive profitabilityFMCG firm Emami Ltd is moving to a need-based advertising strategy rather than blanket promotions to improve profitability.
- Marico buys Paras personal care brands from Reckitt BenckiserMarico has bought the personal care business of Paras Pharmaceuticals from UK consumer goods giant Reckitt Benckiser, edging out Emami.
- Marico buys up personal care brands of Paras Pharmaceuticals from Reckitt BenckiserMarico today acquired a part of the personal care business from Reckitt Benckiser India, which the domestic arm of the British major had bo...
- Emami, Marico, Wipro eye Paras Pharma's Rs 100-crore personal care business from Reckitt BenckiserEmami, Marico and Wipro Consumer are in the final lap to acquire Paras Pharma's 100-crore personal care business from Reckitt Benckiser.
- Wipro, Godrej, Dabur may bid for Reckitt India unitAll three prospective bidders are yet to receive an information memorandum from Reckitt Benckiser specifying details of the sale process.
- Emami may have lost Paras on staff absorptionWhile the absorption of Paras Pharma employees by Reckitt Benckiser has not been discussed yet, but a strong reason why Emami to acquire Ah...
- Paras deal a big shock for us: EmamiIt is an absolute shock,” says Emami Executive Chairman RS Agarwal about his company losing out to Reckitt Benckiser in the race to buy Par...
- The Paras brands we’re acquiring are complementary to our portfolio: Chander Mohan Sethi, Reckitt Benckiser IndiaReckitt Benckiser, maker of Dettol soaps, Harpic toilet cleaner and Vanish stain remover, outdid a number of contenders including Emami to ...
- Reckitt Benckiser may snap up Paras PharmaA leading UK-based company is all set to buy Ahmedabad-based Paras Pharmaceuticals, a person close to the development said.
- Emami frontrunner to bag Paras Pharma for about Rs 3,000 crEmami, which has shown a keen interest in Paras Pharma ever since the beginning of the bidding game, is understood to be shelling out aroun...
- Japan's Taisho leads race for Paras PharmaTaisho Pharmaceuticals has emerged as the front-runner to buy a majority stake in Paras Pharmaceuticals by offering over six times the annu...
- Acquisition gives us opportunities for innovation: Saugata GuptaSaugata Gupta, CEO - Consumer Products, Marico Ltd, spoke to ET Now on Marico looking at picking up controlling stake in Paras Pharma.
- Rivals may join hands for Paras buySome rival potential suitors of Ahmedabad-based Paras Pharmaceuticals are considering the option of co-bidding for the Rs 500-crore company...
- Emami keen on Paras Pharma stake; Godrej, GSKCH deny talksPrivate equity firms Actis and Sequoia that together hold 70% stake are looking to sell their holding at an estimated price of $700 mn.
- Wockhardt challenges patents litigationWockhardt Pharma has just got into the game. The co is challenging Abbott Lab patent on epilepsy drug.
Load More
